SAKK SEMI-ANNUAL MEETING



Similar documents
SAKK SEMI-ANNUAL MEETING

7 th SSHO Invitation to the. 7 th Swiss Summit on Hemato-Oncology

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April :10 14:20 Room C

«THE GENERALISTS AND SPECIALISTS FOR COMPLEX PROJECTS FROM DESIGN TO HANDOVER.»

CHEM-E4140 Selectivity 12. Pharma Business

BREAST CANCER IN YOUNG WOMEN. OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano

OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, AGENDA

EU Clinical Trials Register

Global Non-Small Cell Lung Cancer Therapeutics Market

Cancer Research in Switzerland

STATE OF THE ART INVITATION SATURDAY, JANUARY 30 TH, 2016 COMORBIDITIES AND ENVIRONMENTAL FACTORS INFLUENCING MULTIPLE SCLEROSIS

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015

ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS

ehealthinsight Series: Online Patient Recruitment Strategies

CURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery

APV/IPEC Europe Excipient Conference 2014

INTERPRETING CLINICAL DATA: Highlights From ASCO 2016

Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

KOL Insight: Non-small cell lung cancer Game changing immunotherapies to revolutionise treatment

Direct Democracy: a distinctive feature

PERSONALIZED CANCER TREATMENT A multidisciplinary event

Groundbreaking Collaborative Clinical Trial Launched

PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14

CONSORTIUM OF SWISS ACADEMIC LIBRARIES

16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG

SWISS SOCIETY FOR BIOMATERIALS AND REGENERATIVE MEDICINE NEWSLETTER

Cancer Research in Switzerland

Cancer Research in Switzerland

Dr. Donald A. Keller, Direktor Regionalplanung Zürich und Umgebung RZU

Ask Us About Clinical Trials

Notice of Annual General Meeting

I wish you an inspiring and successful learning experience here in Saint Petersburg. Yours Sincerely, Rachel Clark CEO, EXCEMED

Pharmaceutical industry: 2020 and beyond. Driving prosperity, growth, and competitiveness in Switzerland

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

AUSTRIAN KNEE SYMPOSIUM Sports Medicine Traumatology Prostheses Level: Advanced

The Importance of the Pharmaceutical Industry for Switzerland

Scientific Programme

Press Release Swiss Arbeitgeber Award 2015

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES

INCENTIVE COMPENSATION CONFERENCE

Villejuif, Paris, France

USD 1,500,000 for cancer researchers in Switzerland and Spain

Room for your success

ROOT CAUSE ANALYSIS. Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from Clinical to Post-Market

BIG DATA Driving Evidence for Healthcare Thursday, 5 March :30 17:45 Lecture Hall Pathology C

3 rd SSIPM Congress. December 2-3, 2011 Montreux. Swiss Society for Interventional Pain Management Swiss Neuromodulation Society PROGRAMME

CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010

Annual Press Conference Business Year 2011

17th Annual Continuing Medical Education Conference

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality

Friday 29 th, October 2010

Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019

Curriculum Vitae of Luca Gianni

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

European Post-Merger Integration Survey February 2010

KEEPING CLINICAL TRIALS IN AUSTRALIA

Curriculum Vitae - Sara Gandini

50 Years SAKK. Active Against Cancer!

The Human Right to Science: New Directions for Human Rights in Science

Ending cancer. Together.

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment Chapter3 ValueandSpending...

Guide. Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room. NCCN.org/reimbursement

Metastatic Breast Cancer - Pipeline Review, Q1 2011

Main Conference Agenda

Roots Analysis Pvt. Ltd.

Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer

Rx-360 An International Pharmaceutical Supply Chain Consortium

With the project we hope to bring enhanced treatment for better care of our patients who will no

Employees Employees as at 31 August Employees average during the reporting period

MDC CareerDay April 16, 2015 PROGRAM

The Middle East and the booming Gulf Cooperation Council Thursday, 25 January 2007

2 nd GERMAN-AFRICAN HEALTHCARE SYMPOSIUM

5 th Heidelberg Myeloma Workshop

The Evolution of Data Platforms in IMI. Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg

ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN

Medical Writing Takes Off in India

Corporate culture vs. National culture

Pharmaceutical Products Liability. Michael C. Dubin Stephen Knobloch

Certificate of Banking & Insurance

REGISTER OF INTERESTS SIGN guideline: Management of patients with chronic non-malignant pain Published: 28 November 2013

WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region

International Symposium on Malignant Pleural Mesothelioma

Transcription:

SAKK SEMI-ANNUAL MEETING THURSDAY, NOVEMBER 26, 2015 AND FRIDAY, NOVEMBER 27, 2015 AT THE ZURICH MARRIOTT HOTEL NEUMUEHLEQUAI 42, 8006 ZURICH SAKK COORDINATING CENTER EFFINGERSTRASSE 40 3008 BERNE T +41 31 389 91 91 F +41 31 389 92 00 We bring progress to cancer care

Welcome WELCOME NOTE Berne, October 2015 Dear friends of SAKK, dear madam or sir, dear colleagues It is our pleasure to invite you to the November semi-annual meeting of the SAKK to be held at the Marriot Hotel at the river banks in Zurich. Please find henceforth the program of the meeting, registration details and other general information. 2015 is an exceptional year, as we are celebrating the 50 th anniversary of our SAKK network. This is also reflected in the program, as there will be a 50 Years SAKK Symposium. Achievements of the SAKK during the last 50 years will be presented and the balancing act between social media and data protection will be discussed. Afterwards, you are invited to meet friends and relax at the 50 Years ago themed open end SAKK Jubilee Apéro. Consult the program to see what highlight lies ahead! Beside the jubilee program, there will also be many other meetings and presentations offering insights in science and daily practice. Also, our several groups have invited guests to discuss their fields of specialty. For further information, please consult the scientific program. It is our pleasure to draw your attention to the Satellite Symposium organized by Astellas Pharma AG laying the focus on the way to personalized medicine in prostate cancer and informing about new trends in this field. You may access more information in the separate flyer. Traditionally, we are proud to present the SAKK / Amgen research Grant as well as the GIST Award and a preview to the SAKK/Celgene Grant. Last but not least we look forward to the RTFCCR/SAKK/Gateway Cancer Research Grant presented by the Rising Tide Foundation. We will again have two eventful days contributing to bring progress to cancer care and we look forward to welcoming you in Zurich. Sincerely SAKK Coordinating Center Prof. Dr. Beat Thürlimann President Dr. Peter Brauchli CEO SAKK Bern page 2 / 8

SCIENTIFIC PROGRAM THURSDAY, NOVEMBER 26, 2015 Scientific Program 08.30 09.00 Registration and Welcome Coffee Time Square, 2 nd fl. 09.00 11.00 Joint Meeting: PG Gastro-Intestinal Cancer & Section Surgery ** Co-Chairs: Michael Montemurro, IOSI, Bellinzona Christoph Kettelhack, University Hospital Basel 09.00 10.00 open session with special guest PD Dr. Gunnar Folprecht, Head Oncology, University Hospital of Dresden, Germany EORTC SPECTACOLOR: Update 2015 10.00 11.00 closed session " PG Lymphoma ** Chair: Emanuele Zucca, IOSI, Bellinzona 09.00 10.00 open session 10.00 11.00 closed session " PG Lung Cancer ** Chair: Oliver Gautschi, Cantonal Hospital Luzern 09.00 10.30 open session, with special guest Prof Johan F. Vansteenkiste, University Hospital Gastuisberg, Leuven, Belgium Clinical role of vaccines in NSCLC: where are we going? 10.30 11.00 closed session " Joint Meeting: WG Symptom Control and Palliative Cancer Care & Section Outcomes Research Co-Chair: Florian Strasser, Cantonal Hospital St. Gallen & Konstantin Dedes, University Hospital Zurich Millennium B, 2 nd fl. Index A, ground fl. Sächsilüüte, 4 th fl. Annum, 1 st fl. 09.00 18.00 SPOG, closed session in the North Building Index B, ground fl. 09.30 11.15 SAKK Info for CRCs and Trial Nurses Chair: Peter Durrer, SAKK 09.45 11.15 WG Sarcoma, closed session only Chair: Christian Rothermundt, Cantonal Hospital St. Gallen 11.15 11.45 RTFCCR/SAKK/Gateway Cancer Research Grant Eveline Mumenthaler, Director Rising Tide Foundation Decade, 1 st fl. Tourbillon, 4 th fl. Main Building Century AB, 2 nd fl. 11.45 12.30 Lunch Buffet at Time Square and Millennium Main Building 2 nd fl. 12.30 13.30 Section Surgery Chair: Christoph Kettelhack, University Hospital Basel " Active 2 Kick-off Meeting (by invitation only) Chair: Viviane Hess, University Hospital Basel Chrono, 4 th fl. Tourbillon, 4 th fl. SAKK Bern page 3 / 8

12.30 14.00 Section Network Cancer Predisposition Testing and Counselling (open session) Chair: Pierre Chappuis, University Hospital Geneva with special guest Prof Karl Heinimann, Deputy Director Medical Genetics, University Hospital Basel Opportunities and Threats of Next Generation Sequencing (NGS) 12.30 14.30 PG Urogenital Tumors ** Chair: Richard Cathomas, Cantonal Hospital Grisons 12.30 13.30 open session 13.30 14.30 closed session " PG New Anticancer Drugs ** Chair: Markus Joerger, Cantonal Hospital St. Gallen 12.30 13.30 open session 13.30 14.30 closed session " PG Leukemia ** Chair: Georg Stüssi, IOSI, Bellinzona 12.30 13.30 open session, with special guest Prof Mathilde Hunault, CHU Angers, France GRAALL-2014 protocol - Global overview and focus on Asparaginase therapeutic-drug monitoring 13.30 14.30 closed session cont. Scientific Program Index A, ground fl. Millennium B, 2 nd fl. Decade, 1 st fl. Pendulum, 4 th fl. 12.45 15.00 NICER, closed session in the North Building Sächsilüüte, 4 th fl. 13.45 15.15 Section Radio Oncology, closed session Chair: Ludwig Plasswilm, Cantonal Hospital St. Gallen 14.30 16.00 Satellite Symposium: Astellas Pharma AG On the way to personalized medicine in prostate cancer where do we stand? Click for more information Introduction: Biomarker driven Therapy Decisions in Prostate Cancer Dr med Richard Cathomas, Cantonal Hospital Grisons Tourbillon, 4 th fl. Century AB, 2 nd fl. Landmark Studies on the Treatment of Advanced Prostate Cancer Prof Dr Nick James, Gibbet Hill Campus University of Warwick, UK Predictive Marker Analysis in Prostate Cancer: Current Status and Outlook PD Dr Christian Ruiz, University Hospital Basel 16.00 17.00 Award Ceremonies SAKK / Amgen Research Grant GIST Award Preview Celgene Grant Century AB, 2 nd fl. 17.00 17.30 Coffee break at Time Square and Millennium Main Building 2 nd fl. ** open and closed session SAKK Bern page 4 / 8

cont. Scientific Program 17.30 19.00 SAKK Symposium 50 Years Century AB, 2 nd fl. Click for more information see 2 nd page Welcome: Laudatio SAKK Review SAKK: Achievements of SAKK PD Dr Roger von Moos, Vice President SAKK Cancer Research Two Future Oriented Antipodes Target Medicine & Markers versus Big Data Prof Dr Vincent Mooser, Prof Dr Ernst Hafen The Balancing Act between Social Media and Data Protection Prof Dr Marcel Salathé, Prof Dr jur Beat Rudin Podium Discussion with All Four Speakers Vision or Reality? Closing Remarks PD Dr Roger von Moos, Vice President SAKK 19.00 open end Click for more information SAKK Jubilee Apéro «50 years ago» Podium Discussion with Hans-Jörg Senn SAKK Founding Father & SAKK Past-President (1988 1991) Felix Gutzwiller Preventive Physician, Council of States (2007 Oct. 2015) Mathias Seger Ice Hockey Player ZSC Lions & Captain of Swiss National Ice Hockey Team, SAKK Ambassador Moderation: Tanja Gutmann Millennium, 2 nd fl. FRIDAY, NOVEMBER 27, 2015 08.30 09.00 Registration and Welcome Coffee, Main Building Time Square, 2 nd fl. 09.00 10.30 WG Melanoma Chair: Reinhard Dummer, University Hospital Zurich 09.00 11.00 WG Gynecological Cancer Chair: Mathias Fehr, Hospital Münsterlingen, Frauenfeld " WG Imaging in Diagnostic and Therapy Monitoring Chair: Johannes Heverhagen, Insel Hospital, Bern 10.00 11.30 WG Head and Neck Cancer Chair: Frank Zimmermann, University Hospital Basel 10.30 12.00 WG Central Nervous System Tumors Chair: Andreas Hottinger, CHUV, Lausanne 11.00 11.30 Coffee break & Lunch Bags pick-up, at Time Square and Millennium 11.30 15.30 PG Breast Cancer ** Chair: Thomas Ruhstaller, Cantonal Hospital St. Gallen 11.30 12.15 open session 12.15 15.30 closed session Century A, 2 nd fl. Millennium B, 2 nd fl. Decade, 1 st fl. Annum, 1 st fl. Century B, 2 nd fl. 2 nd fl. Millennium B, 2 nd fl. ** open and closed session SAKK Bern page 5 / 8

General Information INDIVIDUAL MEETING AGEND AS Please make sure to check out the individual meeting agendas of each group which will be available on our website http://sakk.ch/hjv-agendas latest two weeks prior to the meeting. FLOORPLAN MARRIOTT SAKK INDUSTRY POOL PRESENCE The following SAKK industry pool members will be present with an information booth: AstraZeneca AG Booth No. 5 Millennium 2 nd fl. Main Building Astellas Pharma AG Booth No. 4 Millennium 2 nd fl. Main Building Baxalta Schweiz AG Booth No. 9 Millennium 2 nd fl. Main Building Bristol Myers Squibb SA Booth No. 12 (Plus) Time Square 2 nd fl. Main Building Celgene GmbH Booth No. 11 (Plus) Time Square 2 nd fl. Main Building Genomic Health Intl Sàrl Booth No. 7 Millennium 2 nd fl. Main Building Novartis Pharma (Schweiz) AG Booth No. 1 Millennium 2 nd fl. Main Building Pierre Fabre (Suisse) SA Booth No. 10 Millennium 2 nd fl. Main Building Roche Pharma (Schweiz) AG Booth No. 3 Millennium 2 nd fl. Main Building Takeda Pharma AG Booth No. 8 Millennium 2 nd fl. Main Building SAKK Bern page 6 / 8

General Information SAKK AT A GLANCE Organization Non-profit institution, association, founded in 1965 President Vice-President CEO Members Prof Dr med Beat Thürlimann, Head Physician Breast Center St. Gallen PD Dr med Roger von Moos, Head Physician Oncology/Hematology, Chur Dr sc nat Peter Brauchli Cantonal Hospital Aarau, Cantonal Hospital Baden, University Hospital Basel, University Hospital Berne, Hospital Center Bienne, Cantonal Hospital Fribourg, University Hospital Geneva, Cantonal Hospital Grisons, Clinik Hirslanden Zurich, Cantonal Hospital St. Gallen, Hospital STS Ltd. Thun, Hospital Thurgau AG, IOSI (Istituto Oncologico della Svizzera Italiana) Ticino, Hospital Valais, University Hospital Vaud, Cantonal Hospital Winterthur, Cantonal Hospital Luzern, City Hospital Triemli Zurich, University Hospital Zurich Assoc. Members St. László Teaching Hospital, Budapest, Hungary; Centre Paul Strauss, Strassbourg, France; University Hospitals Freiburg, Freiburg i.b, Germany SAKK Industry Pool Amgen Switzerland AG, ARIAD Pharmaceuticals, Astellas Pharma AG, AstraZeneca AG, Baxalta Schweiz AG, Bayer (Schweiz) AG, Boehringer Ingelheim (Schweiz) GmbH, Bristol-Myers Squibb SA, Celgene GmbH, Eli Lilly (Suisse) SA, Genomic Health Intl Sàrl, Gilead Sciences Switzerland Sàrl, Janssen-Cilag AG, Jazz Pharmaceuticals, Lipomed AG, Merck (Schweiz) AG, MSD Merck-Sharp&Dhome AG, Mundipharma Medical Company, Novartis Pharma (Schweiz) AG, Pfizer AG, PharmaMar S.A., Pierre Fabre Pharma AG, Roche Pharma (Schweiz) AG, Sandoz Pharmaceuticals AG, Sanofi-Aventis (Schweiz) AG, Spectrum Pharmaceuticals, Takeda Pharma AG, Teva Pharma AG, Vifor AG Our sincere thanks go to the members of the SAKK Industry Pool. Without the regular financial support from these pharmaceutical companies it would not be possible to hold the SAKK Semi-Annual Meetings on the current scale! We appreciate your support. NEXT SEMI-ANNUAL MEETINGS 2016: Marriott, ZH 2017: Marriott, ZH 2018: Marriott, ZH 2019: Marriott, ZH June 30/July1 June 29/30 June 28/29 June 27/28 Nov 24/25 Nov 23/24 Nov 22/23 Nov 21/22 Please note, our events always take place in week 26 (June) and week 47 (November). SAKK Bern page 7 / 8

GENERAL INFORMATION General Information HOW TO GET THERE The Marriott is in a central location, a mere nine minute stroll along the banks of the river Limmat from Zurich s main train station. You may also use tram N 11 (direction Auzelg) or 14 (direction Seebach) to get to the stop «Beckenhof» two minutes from the hotel. ACCREDITATION The following associations grant credits: SGC-SSC : 15 credits (Thu: 8 pts./fri: 7 pts.) SGR-SSR : 13 credits (Thu: 8 pts./fri: 5 pts.) SGMO : 15 credits (Thu: 9 pts./fri: 6 pts.) SGH-SSH : 5.5 credits (Thu: 4 pts./fri: 1.5 pts.) SRO-SSRO:16 credits (4 pts. per half-day) PARKING The hotel has its own parking at CHF 4/h or CHF 24 for the day. You may also use the parking Sihlquai in in the vicinity of the hotel. REGISTRATION By Friday, November 16, 2015 Online at http://sakk.ch/hjv-registration or by e-mail to events@sakk.ch ORGANIZATION SAKK Coordinating Center Effingerstrasse 40 3008 Bern T +41 31 389 91 91 F +41 31 389 92 00 Contact: Iris Meyer & Caroline Kaminski Event Managers T +41 31 389 91 77 Tram stop 11,14 Marriott Sihlquai 41, 8005 Zurich SAKK Bern page 8 / 8